Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
yangxin dawaimixike migao
- Development stage
- Unknown
- Lead developer
- Guang'anmen Hospital
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Yangxin Dawaimixike Migao is a traditional Chinese medicine (TCM) hospital preparation developed by Guang'anmen Hospital of the China Academy of Chinese Medical Sciences. It is an electuary (honey-based paste) formulated by integrating the traditional Uighur medicine 'Dawayimixik' with TCM principles. The drug is primarily indicated for the treatment of chronic stable angina pectoris, specifically for patients diagnosed with Qi and Yin deficiency and blood stasis syndrome. Its therapeutic effects include nourishing the heart, tranquilizing the mind, and promoting blood circulation to relieve pain. Clinical studies, including multicenter randomized controlled trials, have evaluated its efficacy in reducing the frequency of angina attacks and improving electrocardiogram (ECG) results. The formulation typically includes ingredients such as silk cocoon (Bombyx mori), borage, and other botanical components known in ethnic medicine for their cardioprotective and sedative properties.
- Brand names
- Yangxin Dawaimixike Migao
- Other names
- Yangxin Dawayimixik Migao养心达外米希克蜜膏
Beyond the preview
Go deeper on yangxin dawaimixike migao.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on yangxin dawaimixike migao.